X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28) 28
index medicus (25) 25
male (23) 23
middle aged (22) 22
female (19) 19
aged (18) 18
hematology (17) 17
adult (16) 16
chemotherapy (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
aged, 80 and over (12) 12
oncology (12) 12
cancer (11) 11
care and treatment (11) 11
lymphomas (10) 10
treatment outcome (10) 10
elderly-patients (7) 7
neoplasm staging (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
clinical trials (6) 6
medicine, general & internal (6) 6
prognosis (6) 6
rituximab (6) 6
abridged index medicus (5) 5
analysis (5) 5
antineoplastic agents - therapeutic use (5) 5
medicine & public health (5) 5
non-hodgkins-lymphoma (5) 5
survival rate (5) 5
transplantation (5) 5
young adult (5) 5
adolescent (4) 4
aged patients (4) 4
anthracyclines (4) 4
cancer patients (4) 4
cancer therapies (4) 4
disease-free survival (4) 4
drug administration schedule (4) 4
first-line treatment (4) 4
hodgkin disease - drug therapy (4) 4
lymphoma (4) 4
lymphoma, large b-cell, diffuse - drug therapy (4) 4
maintenance treatment (4) 4
open-label (4) 4
patients (4) 4
progression-free survival (4) 4
prospective studies (4) 4
quality of life (4) 4
recurrence (4) 4
remission induction (4) 4
antimitotic agents (3) 3
antineoplastic agents (3) 3
bendamustine (3) 3
bone-marrow-transplantation (3) 3
clinical medicine (3) 3
clinical-trials (3) 3
combination (3) 3
criteria (3) 3
dlbcl (3) 3
doxorubicin - administration & dosage (3) 3
geriatric assessment (3) 3
geriatrics (3) 3
lymphoma, follicular - diagnosis (3) 3
mantle cell lymphoma (3) 3
multiple myeloma (3) 3
non-hodgkin-lymphoma (3) 3
nursing (3) 3
patient outcomes (3) 3
phase-2 (3) 3
positron-emission-tomography (3) 3
retrospective studies (3) 3
rituximab - administration & dosage (3) 3
stem cell transplantation (3) 3
survival (3) 3
therapy (3) 3
time factors (3) 3
tomography, x-ray computed (3) 3
abvd (2) 2
age factors (2) 2
anti-cd20 monoclonal-antibody (2) 2
antibodies, monoclonal, murine-derived - administration & dosage (2) 2
antibodies, monoclonal, murine-derived - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
autografts (2) 2
bendamustine plus rituximab (2) 2
biopsy (2) 2
bleomycin - administration & dosage (2) 2
breast-cancer (2) 2
carfilzomib (2) 2
chemotherapy plus rituximab (2) 2
clinical trials as topic (2) 2
combined modality therapy (2) 2
comorbidity (2) 2
confidence intervals (2) 2
cyclophosphamide - therapeutic use (2) 2
cytogenetics (2) 2
dacarbazine - administration & dosage (2) 2
daratumumab monotherapy (2) 2
decision making (2) 2
decision-making (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Praxis, ISSN 1661-8157, 10/2016, Volume 105, Issue 21, pp. 1255 - 1260
Journal Article
Lancet, The, ISSN 0140-6736, 04/2015, Volume 385, Issue 9976, pp. 1418 - 1427
Journal Article
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 09/2018, Volume 101, pp. S26 - S27
Journal Article
Swiss Medical Weekly, ISSN 1424-7860, 07/2018, Volume 148, Issue 29-30, p. w14635
Journal Article
Haematologica, ISSN 0390-6078, 07/2012, Volume 97, Issue 7, pp. 1085 - 1091
Journal Article
European journal of cancer care, ISSN 0961-5423, 01/2020, p. e13206
Treatment options for non-small-cell lung cancer (NSCLC) have been evolving. The goal of our study was to evaluate whether novel therapeutics are used in the... 
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2015, Volume 33, Issue 23, pp. 2523 - 2529
Journal Article
Journal Article